Novel Peptide Drugs for Challenging Chronic Metabolic and Neurological Disorders Technology



​Innovative medicines, combining the mirror image of amino acids in our bodies and other modifications, to serve unique patient needs better than biologics, small molecules, and traditional therapies

Resolute discovery platform utilizes patented computational design and synthetic methods to maximize the therapeutic potential of our novel and proprietary technology for an expanding disease target world.



Leadership team from MIT and Harvard with proven ability to discover, develop, and partner novel disease with permeable, stable and nonimmunogeneic peptides.